AUTL — Autolus Therapeutics plc stock price, charts and financials

QT70Autolus Therapeutics plc

Autolus Therapeutics plc (NASDAQ: AUTL) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
1.94
+0.02+1.04%
OverviewShort InterestFilings
AUTLQT70Autolus Therapeutics plc·NASDAQ
1.94+1.04%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 15, 2026DEL AMDEL AM
Sep 14, 2026S-3Shelf registration statement
Sep 03, 20264Statement of changes in beneficial ownership
Aug 28, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 11, 202610-QQuarterly report
Aug 11, 20268-KCurrent report
Aug 03, 20268-KCurrent report
Aug 03, 20268-KCurrent report
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 09, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 202610-QQuarterly report
May 14, 20268-KCurrent report
May 05, 2026EFFECTNotice of effectiveness
#1 / 25 of 213
Page
▼
/ 9